InvestorsHub Logo
Followers 27
Posts 1607
Boards Moderated 0
Alias Born 05/03/2012

Re: peeved post# 369312

Saturday, 08/06/2022 8:42:46 AM

Saturday, August 06, 2022 8:42:46 AM

Post# of 463629
If another P3 is required, there will be a lot of P/O’d share holders because Anavex took a big gamble and set approval back 3-4 years.
Maybe the thinking was that PDD has a 70% correlation with AD so that would qualify. However, for what ever reason, they sat on the PDD data for two years.

I’m still trying to believe in TGD’s quote “when it’s over, you will see why we did what we did “ but I must admit, it’s getting harder to believe.
Why sit on PD/PDD data for two years?
Why is it taking a year and a half to recruit a handful of Rett girls?

Why has Fragile x been promised for two years?
Why so long on the mystery rare indication?
I read that SAVA recruited 300 trial patients rather quickly.
Is the precision medicine focus really worth the years of additional time?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News